Loading…
BioNexus Gene Lab Corp
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in BGLC.
▼ -99.4% over 5Y.
today you would have $9.82▼ -99.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $3.95 | $2.80 | $5.30 | $114.00 | $255.60 | |
| P/S | 9.6x | 1.3x | 0.5x | 9.6x | 181.2x | 327.5x |
| P/B | 9.7x | 1.1x | 0.6x | 9.7x | 297.1x | 609.5x |
| EPS | — | -$0.09 | -$0.17 | — | — |
Companies of similar size in Basic Materials, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CNEYCn Energy Group Inc | $0.59 | — | 0.0x | — | -11.20% | $4.84M |
| CHNRChina Natural Resources Inc | $4.05 | — | 0.4x | — | -1.41% | $5.09M |
| CAPSCapstone Holding Corp. | $0.18 | — | 0.2x | — | -114.21% | $3.77M |
| SNESSenesTech, Inc. | $1.08 |
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Company description provided by Yahoo Finance.
| Profit margin | -16.81% | -40.20% | -16.81% | -26.91% | -3.26% | 5.62% |
| ROE | -19.20% | -34.64% | -19.20% | -27.22% | -5.34% | 10.47% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.9x |
| — |
| -107.42% |
| $5.73M |
| ITPIT Tech Packaging Inc | $0.19 | — | 0.0x | — | -6.92% | $3.18M |
| GUREGulf Resources Inc | $3.90 | — | 0.1x | — | -34.54% | $7.07M |